comparemela.com

Latest Breaking News On - Cellular therapies - Page 8 : comparemela.com

Stock Analysts Updated EPS Estimates for April 24th (ABT, AEYE, AGL, AMZN, ANNX, AOM, ARE, AXON, BIIB, BKR)

Stock Analysts Updated EPS Estimates for April 24th (ABT, AEYE, AGL, AMZN, ANNX, AOM, ARE, AXON, BIIB, BKR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Intra-Cellular Therapies (ITCI) Overweight Rating Reiterated at Cantor Fitzgerald

Intra-Cellular Therapies (ITCI) Overweight Rating Reiterated at Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters Option to Purchase Additional Shares

NEW YORK, April 24, 2024 Intra-Cellular Therapies, Inc.  , a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders,.

Stock Analysts Updated EPS Estimates for April 24th (ABT, AEYE, AGL, AMZN, ANNX, AOM, ARE, AXON, BIIB, BKR)

Stock Analysts Updated EPS Estimates for April 24th (ABT, AEYE, AGL, AMZN, ANNX, AOM, ARE, AXON, BIIB, BKR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canaccord Genuity Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $107 00

Canaccord Genuity Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $107 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.